espa

Announcements

Collaboration Announcement

FARAN S.A. & STADA Arzneimittel AG collaboration announcement FARAN S.A. and STADA Arzneimittel AG are pleased to announce the launch of their collaboration in the field of Osteoporosis. More specifically, FARAN undertakes the promotion and distribution in the Greek market of the STADA Arzneimittel AG product MOVYMIA, the first Biosimilar Teriparatide of STADA Arzneimittel AG.

Learn More

Collaboration Announcement

FARAN S.A. is excited to announce its collaboration with the pharmaceutical company ATNHAS in the field of osteoporosis, concerning the the original drug BONVIVA (Ibandronic acid).

Learn More

Collaboration Announcement – FARAN & MEIJI

FARAN sa is pleased to announce its collaboration with Japanese Pharmaceutical Company MEIJI in the field of infection diseases with the introduction of Spectracef (ceftidoren pivoxil ) , an original third generation cephalosporin.

Learn More

Collaboration Announcement – FARAN SA & SANDOZ

FARAN SA and SANDOZ member of the Novartis Group, after their successful collaboration, are pleased to announce the expansion of their cooperation, undertaking the promotion and distribution of another product with the active substance Epoetin alpha.

Learn More

FARAN SA & NOVARTIS (Hellas) SA collaboration announcement

FARAN SA and NOVARTIS (Hellas) SA are pleased to announce the launch of their collaboration in the field of therapeutic oncology. More specifically, FARAN undertakes the promotion and distribution in the Greek market of the NOVARTIS products TYVERB (Lapatinib) and ZYKADIA (Ceritinib). TYVERB (Lapatinib) is indicated for the treatment of patients with metastatic breast cancer […]

Learn More

Important Distinction for the Greek Pharmaceutical Company Faran SA

Faran SA, one of the historical Pharmaceutical companies with a presence of more than 70 years in the Greek Pharmaceutical market, received the “2018 Pharmaceutical Sector Business Award” from the Internal Medicine Society of Greece, as an acknowledgement of the continuous contribution of Faran to the Healthcare sector and the public health.

Learn More